metricas
covid
Buscar en
Hipertensión y Riesgo Vascular
Toda la web
Inicio Hipertensión y Riesgo Vascular
ISSN: 1889-1837

See more Open Access Option
Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

Indexed in:

Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME

See more

Follow us:

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2023
1.2
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2023
1.7
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2023
0.234
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2023
0.46
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Update on the diagnosis of the pheochromocytoma
E. Achote, O.F. Arroyo Ripoll, M. Araujo-Castro
Available online 11 October 2024
Detección de rigidez arterial en mujeres con antecedente reciente de preeclampsia
A.M. Ghelfi, M.N. Lassus, F.A. Passarino, R.F. Mamprin D’Andrea, L.N. Fierro, L.L. Velez, E.A. Hails, M.A. Paciocco, ... J.O. Galíndez
Available online 10 October 2024
Diseño y racional estudio observacional del Grupo Argentino Estudio Lipoproteína (a)
P. Corral, A. Lavalle Cobo, M.F. Arrupe, L. Schreier, G. Matta, N.F. Renna
Available online 9 October 2024
View all Ahead of print
Current Issue
Issue
Vol. 41. Issue 3.
Pages 143-206 (July - September 2024)
Editorial
HT and uric acid, uric acid and HT: Is hyperuricemia a new vascular risk factor to consider?
Mencia Benitez Camps
Hipertens Riesgo Vasc. 2024;41:143-4
Originales
Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis
R.L. Sanz, F. García, A. Gutierrez, S. García Menendez, F. Inserra, L. Ferder, W. Manucha
Hipertens Riesgo Vasc. 2024;41:145-53
Assessing levels of uric acid and other cardiovascular markers in prehypertensive and hypertensive adults
L. da Cunha Agostini, L.A. Cota e Souza, N.N.T. Silva, A.C.F. Lopes, L.F. de Medeiros Teixeira, V. de Almeida Belo, W. Coura-Vital, G.N. da Silva, A.A. Lima
Hipertens Riesgo Vasc. 2024;41:154-61
Metabolic biomarkers and cardiovascular risk stratification in hypertension
D. Piskorz, L. Keller, L. Citta, G. Tissera, L. Mata, L. Bongarzoni
Hipertens Riesgo Vasc. 2024;41:162-9
View all issue
Free access article
Review
Diuretics use in the management of hypertension
F.J. Morales-Olivas
10.1016/j.hipert.2024.03.004
Hipertens Riesgo Vasc. 2024;41:186-93
Archive
View all archive
Supplements
View all supplements
Instructions for authors
Most often read
Review
F.J. Morales-Olivas
10.1016/j.hipert.2024.03.004
Hipertens Riesgo Vasc. 2024;41:186-93
This article has been read 1.830 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos